David Henry
Impact in
- Biochemistry top 0.1%
- Blood transfusion and management
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 40
- Pharmaceutical Economics and Policy 29
-
- Primary Care and Health Outcomes 10
- Co-authors
- Patricia McGettigan (13 shared papers)Beverley Shea (4 shared papers)George A. Wells (2 shared papers)Candyce Hamel (2 shared papers)Elizabeth Kristjansson (2 shared papers)Peter Tugwell (5 shared papers)Barnaby C Reeves (1 shared paper)David Moher (1 shared paper)
- Journals
- The Medical Journal of Australia (39 papers)Cochrane Database of Systematic Reviews (13 papers)PLoS Medicine (12 papers)British Journal of Clinical Pharmacology (10 papers)The Lancet (10 papers)
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
David Henry
331 papers receiving 24.9k citations
David Henry's Hit Papers
Peers
Comparison fields: 5 of 229
- Biochemistry 1.5k
- Critical Care and Intensive Care Medicine 794
- Pharmacology 2.6k
- Pharmacology 1.2k
- Statistics, Probability and Uncertainty 1.0k
Countries citing papers authored by David Henry
This map shows the geographic impact of David Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Henry more than expected).
Fields of papers citing papers by David Henry
This network shows the impact of papers produced by David Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Henry. The network helps show where David Henry may publish in the future.
Co-authors
The 25 scholars most cited alongside David Henry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 340 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both Hit paper breakdown → | 2017 | 7098 |
| 2 | AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews Hit paper breakdown → | 2009 | 1435 |
| 3 | Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group Hit paper breakdown → | 2004 | 901 |
| 4 | Cardiovascular Risk and Inhibition of Cyclooxygenase Hit paper breakdown → | 2006 | 867 |
| 5 | Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis Hit paper breakdown → | 1996 | 659 |
| 6 | Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Hit paper breakdown → | 2011 | 652 |
| 7 | A population-based study of the drug interaction between proton pump inhibitors and clopidogrel Hit paper breakdown → | 2009 | 549 |
| 8 | Preventing overdiagnosis: how to stop harming the healthy Hit paper breakdown → | 2012 | 460 |
| 9 | Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies Hit paper breakdown → | 2011 | 449 |
| 10 | 1998 | 448 | |
| 11 | 1995 | 413 | |
| 12 | 2000 | 406 | |
| 13 | 2000 | 373 | |
| 14 | 2010 | 326 | |
| 15 | 2013 | 324 | |
| 16 | 2002 | 279 | |
| 17 | 1995 | 244 | |
| 18 | 1993 | 240 | |
| 19 | 1996 | 226 | |
| 20 | 1995 | 216 |
About David Henry
David Henry is a scholar working on Economics and Econometrics, General Health Professions, Pharmacology, Surgery and Pharmacology, having authored 340 papers that have together received 26.4k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (40 papers), Pharmaceutical Economics and Policy (29 papers), Inflammatory mediators and NSAID effects (22 papers), Pharmaceutical industry and healthcare (21 papers), Pharmaceutical studies and practices (15 papers), Primary Care and Health Outcomes (10 papers), Blood transfusion and management (10 papers) and Rhetoric and Communication Studies (10 papers). The work is most often cited by research in Biochemistry (1.5k citations), Critical Care and Intensive Care Medicine (794 citations), Pharmacology (2.6k citations), Pharmacology (1.2k citations) and Statistics, Probability and Uncertainty (1.0k citations). David Henry has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Patricia McGettigan, Beverley Shea, George A. Wells, Candyce Hamel, Elizabeth Kristjansson, Peter Tugwell, Barnaby C Reeves, David Moher, Micere Thuku and Vivian Welch. Their work appears in journals such as The Medical Journal of Australia, Cochrane Database of Systematic Reviews, PLoS Medicine, British Journal of Clinical Pharmacology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.